Hongbin Sun
- Cancer Research top 10%
- Molecular Biology top 10%
- Protein Structure and Dynamics 3
- RNA modifications and cancer 3
- Glycosylation and Glycoproteins Research 3
- Cell Biology top 5%
- Microtubule and mitosis dynamics 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
- Microbiology top 10%
- Antimicrobial Peptides and Activities 4
-
- Nanoplatforms for cancer theranostics 3
-
- Enzyme Production and Characterization 3
- Journals
- Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hongbin Sun
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 246
- Molecular Biology 1.0k
- Cell Biology 218
- Biomaterials 165
- Microbiology 63
Countries citing papers authored by Hongbin Sun
This map shows the geographic impact of Hongbin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Sun more than expected).
Fields of papers citing papers by Hongbin Sun
This network shows the impact of papers produced by Hongbin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Sun. The network helps show where Hongbin Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2020 | 32 | |
| 4 | 2019 | 4 | |
| 5 | 2019 | 14 | |
| 6 | 2018 | 298 | |
| 7 | 2018 | 2 | |
| 8 | 2017 | 41 | |
| 9 | 2017 | 6 | |
| 10 | 2015 | 293 | |
| 11 | 2015 | 9 | |
| 12 | 2014 | 27 | |
| 13 | 2014 | 12 | |
| 14 | 2011 | 9 | |
| 15 | Recent research and development of nucleoside analogues as antimetabolite agents | 2010 | 1 |
| 16 | Research progress of prostaglandin receptors and related drugs | 2010 | 1 |
| 17 | Synthesis and in vitro antitumor activities of novel soladulcidine derivatives | 2010 | 2 |
| 18 | 2007 | 8 | |
| 19 | 2007 | 8 | |
| 20 | 2006 | 19 |
About Hongbin Sun
Hongbin Sun is a scholar working on Microbiology, Toxicology and Molecular Biology, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Protein Structure and Dynamics (3 papers), Microtubule and mitosis dynamics (3 papers), Nanoplatforms for cancer theranostics (3 papers), RNA modifications and cancer (3 papers), Enzyme Production and Characterization (3 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cancer Research (246 citations), Molecular Biology (1.0k citations) and Cell Biology (218 citations). Hongbin Sun has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chao Xu, Shanhui Liao, Junfeng Wang, Jiarong Wang, Gaolin Liang, Xuelian Luo, Hongtao Yu, Bing Hu, Shuchao Ge and Yue Yuan. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.